Clinical Trials

Showing trials with last updates posted in 2026.

NCT07781852 | NOT_YET_RECRUITING | EARLY_PHASE1
40 participants

Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2026-09-01
Completion:
2027-09-01
Conditions
  • Bladder Cancer
  • Glioma
  • Glioblastoma (GBM)
  • Breast Cancer
  • Colorectal Cancer
  • Esophageal Cancer
  • Gastric Cancer (GC)
  • Pharynx Cancer
  • Oral Cavity Cancer
  • Kidney Cancer
  • Liver Cancer
  • Lung Cancer (NSCLC)
  • Ovarian Cancer
  • Pancreatic Cancer
  • PDAC - Pancreatic Ductal Adenocarcinoma
  • Prostate Cancer
Interventions
  • DRUG
  • DEVICE
  • PROCEDURE
No Results Yet
NCT07780266 | NOT_YET_RECRUITING | NA
36 participants

Physiology of Liberation

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2026-09-30
Completion:
2027-08-31
Conditions
  • Psychophysiological Reactivity and Recovery
Interventions
  • BEHAVIORAL
No Results Yet
NCT07768358 | NOT_YET_RECRUITING | PHASE4
175 participants

Tucatinib Continuation Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2026-11-06
Completion:
2032-03-13
Conditions
  • HER2-positive Breast Cancer
  • Cervical Cancer
  • Biliary Tract Neoplasms
  • Urothelial Cancer
  • Advanced Non-Small Cell Lung Cancer
  • Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)
  • Colorectal Cancer
Interventions
  • DRUG
No Results Yet
NCT07703436 | NOT_YET_RECRUITING | PHASE2
40 participants

Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2027-03-31
Completion:
2030-09-30
Conditions
  • Grade 2 IDH1-mutant Glioma
  • Grade 3 IDH1-mutant Glioma
  • Glioma
  • IDH1-mutant Glioma
  • Oligodendroglioma
  • Oligodendroglioma IDH-1 Mutant and 1/p19q-codeleted
  • Astrocytoma IDH Mutant Grade 3
  • Astrocytoma IDH Mutant Grade 2
Interventions
  • DRUG
No Results Yet
NCT07680244 | RECRUITING | NA
400 participants

(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2025-05-23
Completion:
2026-08-31
Conditions
  • Epiretinal Membrane
  • Dry Age Related Macular Degeneration
  • Macular Abnormalities
  • Retina Disease
  • Vitreoretinal Abnormality
  • Intraretinal Hyporeflective Space
  • Subretinal Hyporeflective Space
  • IS/OS (Ellipsoid Zone) Disruption
  • Retinal Pigment Epithelium (RPE) Elevation
  • Retinal Pigment Epithelium (RPE) Atrophy
Interventions
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page